Autosomal recessive adult-onset amyohophic lateral sclerosis associated with homozygosity for Asp90A1a CuZn-superoxide dismutase mutation A clinical and genealogical study of 36 patients

Brain

Volumn 119, Issue 4, 1996, Pages 1153-1172

  Andersen, P M ^a   Forsgren, L ^a   Binzer, M ^a   Nilsson, P ^a   Ala Hurula, V ^b   Keranen M L ^c   Bergmark, L ^a   Saarinen, A ^d   Haltia, T ^e   Tarvainen, I ^f   Kinnunen, E ^g   Udd, B ^h   Marklund, S L ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b Kemi Central Hospital   (Finland)

^c LAPLAND CENTRAL HOSPITAL   (Finland)

^d Kainuun Keskussairaala ^*  (Finland)

^e Kauniala Hosp for Injured Veterans   (Finland)

^f MIKKELI CENTRAL HOSPITAL   (Finland)

^g HYVINKÄÄ HOSPITAL   (Finland)

^h Vaasa City Hospital   (Finland)

Author keywords

Asp90a1a CuZn SOD mutation; Autosomal recessive adult onset amyotrophic lateral sclerosis; Motor neuron disease

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARM; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; DISEASE COURSE; DISEASE DURATION; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; FINLAND; GENE MUTATION; HOMOZYGOSITY; HUMAN; MALE; MICTURITION; MOTONEURON; MOTOR SYSTEM; MUSCLE SPASM; NERVE CONDUCTION; ONSET AGE; PARESIS; PRIORITY JOURNAL; SURVIVAL TIME; SWEDEN; SYMPTOM; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 9544236295     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/119.4.1153     Document Type: Article

References (88)

1. Alter M, Shaumann B. A family with amyotrophic lateral sclerosis and parkinsonism. J Neurol 1976; 212: 281-4.
2. Andersen PM, Nilsson P, Ala-Hurula V, Keränen M-L, Tarvainen I, Haltia T, et al. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in Cu/Zn-superoxide dismutase. Nat Genet 1995; 10: 61-6.
3. Aoki M, Ogasawara M, Matsubara Y, Narisawa K, Nakamura S, Itoyama Y, et al.Mild ALS in Japan associated with novel SOD mutation [letter] [published erratum appears in Nat Genet 1994; 6: 225]. Nat Genet 1993; 5: 323-4.
4. Aoki M, Ogasawara M, Matsubara Y, Narisawa K, Nakamura S, Itoyama Y, et al. Familial amyotrophic lateral sclerosis (ALS) in Japan associated with H46R mutation in CuZn superoxide dismutase gene: a possible new subtype of familial ALS. J Neurol Sci 1994; 126: 77-83.
5. Appel SH. A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer's disease. Ann Neurol 1981; 10: 499-505.
6. Appel SH, Stockton-Appel V, Stewart SS, Kerman RH. Amyotrophic lateral sclerosis. Associated clinical disorders and immunological evaluations. Arch Neurol 1986; 43: 234-8.
7. Aran FA. Recherches sur une maladie non encore décrite du système musculaire (atrophie musculaire progressive). Arch Gén Méd 1850; 24: 4-35, 172-214.
8. Bandmann O, Davis MB, Marsden CD, Handing AE. Sequence of the superoxide dismutase 1 (SOD 1) gene in familial Parkinson's disease. J Neurol Neurosurg Psychiatry 1995; 59: 90-1.
9. Barker AT, Freeston IL, Jalinous R, Jarratt JA. Clinical evaluation of conduction time measurements in central motor pathways using magnetic stimulation of human brain [letter]. Lancet 1986; 1: 1325-6.
10. Beckman G. Population studies in northern Sweden. VI. Polymorphism of superoxide dismutase. Hereditas 1973; 73: 305-10.
11. Beckman G, Pakarinen A. Superoxide dismutase. A population study. Hum Hered 1973; 23: 346-51.
12. Beckman G, Beckman L, Nilsson L-O. Genetics of human superoxide dismutase. Hereditas 1975; 79: 43-6.
13. Ben Hamida M, Hentati F, Ben Hamida C. Hereditary motor system diseases (chronic juvenile amyotrophic lateral sclerosis). Brain 1990; 113: 347-63.
14. Berardelli A, Inghilleri M, Formisano R, Accornero N, Manfredi M. Stimulation of motor tracts in motor neuron disease. J Neurol Neurosurg Psychiatry 1987; 50: 732-7.
15. Berardelli A, Inghilleri M, Cruccu G, Mercuri B, Manfredi M. Electrical and magnetic transcranial stimulation in patients with corticospinal damage due to stroke or motor neurone disease. Electroencephalogr Clin Neurophysiol 1991; 81: 389-96.
16. Brait K, Fahn S, Schwarz GA. Sporadic and familial parkinsonism and motor neuron disease. Neurology 1973; 23: 990-1002.
17. Brown WF, Ebers GC, Hudson AJ, Pringle CE, Veitch J. Motorevoked responses in primary lateral sclerosis. Muscle Nerve 1992; 15: 626-9.
18. Burrow JNC, Blumbergs PC. Substantia nigra degeneration in motor neurone disease: a quantitative study. Aust NZJ Med 1992; 22: 469-72.
19. Calne DB, Eisen A, McGeer E, Spencer P. Alzheimer's disease, Parkinson's disease, and motoneurone disease: abiotrophic interaction between ageing and environment? Lancet 1986; 2: 1067-70.
20. Campbell AMG, Williams ER, Barltrop D. Motor neurone disease and exposure to lead. J Neurol Neurosurg Psychiatry 1970; 33: 877-85.
21. Caramia MD, Cicinelli P, Paradiso C, Mariorenzi R, Zarola F, Bernardi G, et al. 'Excitability' changes of muscular responses to magnetic brain stimulation in patients with central motor disorders. Electroencephalogr Clin Neurophysiol 1991; 81: 243-50.
22. Charcot JM, Joffroy A. Deux cas d'atrophie musculaire progressive avec lésions de la substance grise et des faisceaux antéro-latéraux de la moëlle épinière. Arch Physiol Norm Path 1869; 2: 744-60.
23. Chio A, Brignolio F, Meineri P, Schiffer D. Phenotypic and genotypic heterogeneity of dominantly inherited amyotrophic lateral sclerosis. Acta Neurol Scand 1987; 75: 277-82.
24. Deapen DM, Henderson BE. A case-control study of amyotrophic lateral sclerosis. Am J Epidemiol 1986; 123: 790-9.
25. de Belleroche J, Orrell R, King A. Familial amyotrophic lateral sclerosis/motor neurone disease (FALS): a review of current developments. J Med Genet 1995; 32: 841-7.
26. Drake ME Jr. Chronic pain syndrome in amyotrophic lateral sclerosis. Arch Neurol 1983; 40: 453-4.
27. Eisen A, Calne D. Amyotrophic lateral sclerosis, Parkinson's disease and Alzheimer's disease: phylogenetic disorders of the human neocortex sharing many characteristics. [Review]. Can J Neurol Sci 1992; 19 (1 Suppl): 117-23.
28. Eisen AA, Shytbel W. AAEM minimonograph: 35: clinical experience with transcranial magnetic stimulation. Muscle Nerve 1990; 13: 995-1011.
29. Eisen A, Shytbel W, Murphy K, Hoirch M. Cortical magnetic stimulation in amyotrophic lateral sclerosis. Muscle Nerve 1990; 13: 146-51.
30. Eisen A, Schulzer M, MacNeil M, Pant B, Mak E. Duration of amyotrophic lateral sclerosis is age dependent. Muscle Nerve 1993; 16: 27-32.
31. Emery AEH, Holloway S. Familial motor neuron diseases. In: Rowland LP, editor. Human motor neuron diseases. New York: Raven Press, 1982: 139-47.
32. Eriksson AW. Genetic polymorphisms in Finno-Ugrian populations. Isr J Med Sci 1973; 9: 1156-70.
33. Felmus MT, Patten BM, Swanke L. Antecedent events in amyotrophic lateral sclerosis. Neurology 1976; 26: 167-72.
34. Forrester JM. Amyotrophic lateral sclerosis and bedsores [letter]. Lancet 1976; 1: 970.
35. Forsgren L, Almay BGL, Holmgren G, Wall S. Epidemiology of motor neuron disease in northern Sweden. Acta Neurol Scand 1983; 68: 20-9.
36. Frecker MF, Fraser FC, Andermann E, Pryse-Phillips WEM. Association between Alzheimer disease and amyotrophic lateral sclerosis [see comments]? Can Neurol Sci 1990; 17: 12-4. Comment in: Can J Neurol Sci 1990; 17: 352.
37. Friedman AP, Freedman DA, Amyotrophic lateral sclerosis. J Nerv Ment Disord 1950; 111: 1-18.
38. Gallagher JP, Sanders M. Trauma and amyotrophic lateral sclerosis: a report of 78 patients. Acta Neurol Scand 1987; 75: 145-50.
39. Giménez-Roldán S, Esteban A. Prognosis in hereditary amyotrophic lateral sclerosis. Arch Neurol 1977; 34: 706-8.
40. Granieri E, Carreras M, Tola R, Paolino E, Tralli G, Eleopra R, et al. Motor neuron disease in the province of Ferrara, Italy, in 1964-1982. Neurology 1988; 38: 1604-8.
41. Gubbay SS, Kahana E, Zilber N, Cooper G, Pintov S, Leibowitz Y. Amyotrophic lateral sclerosis. A study of its presentation and prognosis. J Neurol 1985; 232: 295-300.
42. Gunnarsson L-G, Lindberg G, Söderfeldt B, Axelson O. Amyotrophic lateral sclerosis in Sweden in relation to occupation. Acta Neurol Scand 1991a; 83: 394-8.
43. Gunnarsson L-G, Dahlbom K, Strandman E. Motor neuron disease and dementia reported among 13 members of a single family. Acta Neurol Scand 1991b; 84: 429-33.
44. Gunnarsson L-G, Bodin L, Söderfeldt B, Axelson O. A case-control study of motor neurone disease: its relation to heritability, and occupational exposures, particularly to solvents. Br J Ind Med 1992; 49: 791-8.
45. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation (see comments). Science 1994; 264: 1772-5. Comment in: Science 1994; 264: 1663-4. Comment in: Science 1994; 266: 1586-7.
46. Hattori T, Hirayama K, Yasuda K, Shimazaki J. Disturbance of micturition in amyotrophic lateral sclerosis.[Japanese]. Rinsho Shinkeigaku 1983; 23: 224-7.
47. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Brain 1995; 118: 707-19.
48. Hayashi H, Kato S. Total manifestations of amyotrophic lateral sclerosis: ALS in the totally locked-in state. J Neurol Sci 1989; 93: 19-35.
49. Hirano A, Kurland LT, Sayre GP. Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells. Arch Neurol 1967; 16: 232-43.
50. Horton WA, Eldridge R, Brody JA. Familial motor neuron disease. Evidence for at least three different types. Neurology 1976; 26: 460-5.
51. Hudson AJ. Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. [Review]. Brain 1981; 104: 217-47.
52. Ingram DA, Swash M. Central motor conduction is abnormal in motor neuron disease. J Neurol Neurosurg Psychiatry 1987; 50: 159-66.
53. Jokelainen M. Amyotrophic lateral sclerosis in Finland. II: Clinical characteristics. Acta Neurol Scand 1977; 56: 194-204.
54. Jones CT, Swingler RJ, Simpson SA, Brock DJH. Superoxide dismutase mutations in an unselected cohort of Scottish amyotrophic lateral sclerosis patients. J Med Genet 1995; 32: 290-2.
55. Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset: a sex-linked recessive trait. Neurology 1968; 18: 671-80.
56. Kirjarinta M, Fellman J, Gustafsson C, Keisala E, Eriksson AW. Two rare electrophoretic variants of erythrocyte enzymes in Finland [abstract]. Scand J Clin Lab Invest 1969; 23: Suppl 108: 46.
57. Kurland LT, Mulder DW. Epidemiologic investigations of amyotrophic lateral sclerosis. Familial aggregations indicative of dominant inheritance. Part I & II. Neurology 1955; 5: 182-96; 249-68.
58. Li T-M, Alberman E, Swash M. Comparison of sporadic and familial disease amongst 580 cases of motor neuron disease. J Neurol Neurosurg Psychiatry 1988; 51: 778-84.
59. López-Vega JM, Calleja J, Combarros O, Polo JM, Berciano J. Motor neuron disease in Cantabria. Acta Neurol Scand 1988; 77: 1-5.
60. Majoor-Krakauer D, Ottman R, Johnson WG, Rowland LP. Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson's disease: evidence of shared genetic susceptibility. Neurology 1994; 44: 1872-7.
61. Metcalf CW, Hirano A. Amyotrophic lateral sclerosis. Clinicopathological studies of a family. Arch Neurol 1971; 24: 518-23.
62. Mills KR. Motor neuron disease. Studies of the corticospinal excitation of single motor neurons by magnetic brain stimulation. Brain 1995; 118: 971-82.
63. Mulder DW, Howard FM Jr. Patient resistance and prognosis in amyotrophic lateral sclerosis. Mayo Clin Proc 1976; 51: 537-41.
64. Mulder DW, Rosenbaum RA, Layton DD Jr. Late progression of poliomyelitis or forme fruste amyotrophic lateral sclerosis? Mayo Clin Proc 1972; 47: 756-61.
65. Mulder DW, Kurland LT, Offord KP, Beard CM. Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology 1986; 36: 511-7.
66. Müller R. Progressive motor neuron disease in adults. Acta Psychiat Neurol Scand 1952; 27: 137-56.
67. Murray TJ, Pride S, Haley G. Motor neuron disease in Nova Scotia. Can Med Assoc J 1974; 110: 814-7.
68. Myllylä VV, Toivakka E, Ala-Hurula V, Hokkanen E, Emeryk-Szajewska B. Juvenile amyotrophic lateral sclerosis. A report of two cases in a single family. Acta Neurol Scand 1979; 60: 170-7.
69. Nakano R, Sato S, Inuzuka T, Sakimura K, Mishina M, Takahashi H, et al. A novel mutation in Cu/Zn superoxide dismutase gene in Japanese familial amyotrophic lateral sclerosis. Biochem Biophys Res Commun 1994; 200: 695-703.
70. Orrell RW, King AW, Hilton DA, Campbell MJ, Lane RJM, de Belleroche J. Familial amyotrophic lateral sclerosis with a point mutation of SOD-1: intrafamilial heterogeneity of disease duration associated with neurofibrillary tangles. J Neurol Neurosurg Psychiatry 1995a; 59: 266-70.
71. Orrell R, de Belleroche J, Marklund S, Bowe F, Hallewell R. A novel SOD mutant and ALS [letter]. Nature 1995b; 374: 504-5.
72. Osuntokun BO, Adeuja AOG, Bademosi O. The prognosis of motor neuron disease in Nigerian africans. Brain 1974; 97: 385-94.
73. Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain 1992; 115: 495-520.
74. Roe PF. Familial motor neurone disease. J Neurol Neurosurg Psychiatry 1964; 27: 140-3.
75. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis [published erratum appears in: Nature 1993; 364: 362] [see comments]. Nature 1993; 362: 59-62. Comment in Nature 1993; 362: 20-1.
76. Rosen DR, Bowling AC, Patterson D, Usdin TB, Sapp P, Mezey E, et al. A frequent ala 4 to val superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3: 981-7.
77. Russo LS Jr. Clinical and electrophysiological studies in primary lateral sclerosis. Arch Neurol 1982; 39: 662-4.
78. Schmitt HP, Emser W, Heimes C. Familial occurrence of amyotrophic lateral sclerosis, parkinsonism, and dementia. Ann Neurol 1984; 16: 642-8.
79. Schriefer TN, Hess CW, Mills KR, Murray NMF. Central motor conduction studies in motor neurone disease using magnetic brain stimulation. Electroencephalogr Clin Neurophysiol 1989; 74: 431-7.
80. Schröder HD, Reske-Nielsen E. Preservation of the nucleus X-pelvic floor motosystem in amyotrophic lateral sclerosis. Clin Neuropathol 1984; 3: 210-6.
81. Siddique T, Figlewicz DA, Pericak-Vance MA, Haines JL, Rouleau G, Jeffers AJ, et al. Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity [published errata appear in N Engl J Med 1991; 325: 71 and 1991; 325: 524] [see comments]. N Eng J Med 1991; 324: 1381-4. Commnt in: N Engl J Med 1991; 324: 1430-2, comment in: N Engl J Med 1991; 325: 1328-3.
82. Själander A, Beckman G, Deng H-X, Iqbal Z, Tainer JA, Siddique T. The D90A mutation results in a polymorphism of Cu.Zn superoxide dismutase that is prevalent in northern Sweden and Finland. Hum Mol Genet 1995; 4: 1105-8.
83. Strong MJ, Hudson AJ, Alvord WG. Familial amyotrophic lateral sclerosis 1850-1989: a statistical analysis of the world literature. Can J Neurol Sci 1991; 18: 45-58.
84. Suthers G, Laing N, Wilton S, Dorosz S, Waddy H. 'Sporadic' motoneuron disease due to familial SOD1 mutation with low penetrance [letter]. Lancet 1994; 344: 1773.
85. Swank RL, Putnam TJ. Amyotrophic lateral sclerosis and related conditions. A clinical analysis. Arch Neurol Psychiatry 1943; 49: 151-77.
86. Wechsler IS, Brock S, Weil A. Amyotrophic lateral sclerosis, with objective and subjective (neuritic) sensory disturbances. Arch Neurol Psychiatry 1929; 21: 299-310.
87. Williams DB, Floate DA, Leicester J. Familial motor neuron disease: differing penetrance in large pedigrees. J Neurol Sci 1988; 86: 215-30.
88. Woodall CJ, Riding MH, Graham DI, Clements GB. Sequences specific for enterovirus detected in spinal cord from patients with motor neurone disesae [see comments]. BMJ 1994; 308: 1541-3. Comment in: BMJ 1994; 309: 743. Comment in: BMJ 1995; 310: 256